Inhibition of the Glycolytic-enzymes in the Trypanosome - An Approach in the Development of New Leads in the Therapy of Parasitic Diseases

Perié, J.;Rivierealric, I.;Blonski, C.;Gefflaut, T.;Callens, M.;et.al.
(1993) 4th International Symposium on Molecular Aspects of Chemotherapy — Location: GDANSK(Poland) (23.June.1993)

Files

No attached file found for this publication.

Details

Authors
  • Perié, J.
    Author
  • Rivierealric, I.
    Author
  • Blonski, C.
    Author
  • Gefflaut, T.
    Author
  • Opperdoes, FrederikUCLouvain
    Author
  • Callens, M.
    Author
Show more
Abstract
Glycolysis in the trypanosome represents an important target for the development of new therapeutic agents due to the fact that this metabolism is essential for the parasite, glucose being its sole source of energy. In addition, different features of this metabolism and those associated with glycolytic enzymes offer opportunities for the development of efficient and selective compounds. Examples are given in this work of inhibitors directed to the enzymes aldolase and glyceraldehyde-phosphate-dehydrogenase and also of molecules acting specifically on the clusters of basic amino-acids present at the surfaces of the glycolytic enzymes in the parasite.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Perié, J., Rivierealric, I., Blonski, C., Gefflaut, T., Deviguerie, NL., Trinquier, M., Willson, M., Opperdoes, F., & Callens, M. (1993). Inhibition of the Glycolytic-enzymes in the Trypanosome - An Approach in the Development of New Leads in the Therapy of Parasitic Diseases. Pharmacology & Therapeutics, 60(2), 347-365. https://hdl.handle.net/2078.5/63855 (Original work published 1993)